Past Issue: July–August 2011
Interventions and Assessments
- FDA Approves Long-Acting Injectable Naltrexone for Opioid Dependence
- Low-dose Topiramate for Alcohol Dependence
- Brief Intervention May Have Efficacy for Alcohol Dependence in Emergency Departments
- Home- versus Office-based Buprenorphine Induction: Impact on Opioid and Other Drug Use
- Supervised Injecting Facilities Associated with a Reduction in Overdose Mortality
- Treatment of Tuberculosis with Rifampin Induces Opioid Withdrawal in Patients Maintained on Buprenorphine
- How They Do It: Physicians Describe Building a Physician-Patient Relationship with People Who Use Illicit Drugs
- Higher Prescribed Opioid Doses Are Associated with Overdose Deaths
- Opioid-related Death in Patients with Nonmalignant Pain
- Predictors of Seizures and Delirium Tremens in the Course of Alcohol Withdrawal
- Subtle Change in Drinking Guidelines Could Have Increased Alcohol-related Harm
- Lower Risk of Heart Disease from Alcohol, Even with Hazardous Drinking?
A FREE federally funded* educational service providing clinicians with a broad range of resources to address substance abuse, including
- instruments to screen patients for unhealthy substance use.
- informational materials to engage patients in conversations about substance use.
- tools that save time by pinpointing substance-abuse related problems.
- speakers for CME programs on subjects related to alcohol and drug use.
- evidence-based resources to educate future and current physicians.